MAPT and tauopathy: In the last decade, numerous studies have demonstrated antiinflammatory and neuroprotective effects of different pharmacological molecules in tauopathy brains (23), but in the absence of proper knowledge about tau-induced receptor activation in glial cells, these approaches might face several challenges.